home / stock / afmd / afmd articles

AFMD Articles, Affimed N.V. - From 11/06/23

Stock Information
Company Name: Affimed N.V.
Stock Symbol: AFMD
Market: NASDAQ
Website: affimed.com
Menu
AFMD AFMD Quote AFMD Short AFMD News AFMD Articles AFMD Message Board
Get AFMD Alerts

News, Short Squeeze, Breakout and More Instantly...
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The com...
Affimed Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types at the 38th Annual Meeting of the Society for Immunotherapy of Cancer | Benzinga

Addition of Affimed's innate cell engager (ICE®) improves cytotoxicity of natural killer (NK) cells and CAR-NK cells NK cells with ICE&...

Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting | Benzinga

In 36 patients with CD30-positive lymphoma treated at the recommended Phase 2 dose level (RP2D), the combination treatment of AFM13 with allogene...

Affimed to Participate in Upcoming Investor Conferences | Benzinga

MANNHEIM, Germany, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD) ("Affimed" or the "Company"), a clinical-stage immuno-oncology c...
Affimed Announces Acceptance of an Abstract Comparing NK Cells Redirected by Innate Cell Engagers and CAR-NK Cells for Poster Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer | Benzinga

MANNHEIM, Germany, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD) ("Affimed", or the "Company"), a clinical-stage immuno-oncology...

Affimed to Present at the Cantor Global Healthcare Conference 2023 | Benzinga

MANNHEIM, Germany, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD) ("Affimed", or the "Company"), a clinical-stage immuno-oncology...

Affimed to Present at the H.C. Wainwright Annual Global Investment Conference | Benzinga

HEIDELBERG, Germany, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving...
Previous 10 Next 10